Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study
Nuria Romero-Laorden, David Lorente, Guillermo de Velasco, R. Lozano Mejorada, Bernardo Herrera‐Imbroda, Javier Puente, Pedro P. López‐Casas, Ana Medina, Elena Almagro, Enrique González‐Billalabeitia, Jose Carlos Villla-Guzman, Aranzazu González del Alba, Pablo Borrega, Núria Laínez, Ana Fernández-Freire, Amaia Hernández, Alejo Rodríguez‐Vida, Isabel Chirivella, E. Fernández-Parra, Fernando López‐Campos, Maria Isabel Ribas Pacheco, Rafael Morales‐Barrera, Ovidio Fernández, R. Villatoro, Raquel Luque, Susana Hernando, Daniel C. Castellano, Elena Castro, David Olmos
Topics & Concepts
MedicineProstate cancerN-terminal telopeptideInternal medicinePyridinolineProspective cohort studyBone remodelingRadium-223OncologyProportional hazards modelProstate-specific antigenBone resorptionConfidence intervalBone metastasisHazard ratioCancerUrologyAlkaline phosphataseOsteocalcinBiochemistryChemistryEnzymeProstate Cancer Treatment and ResearchBone health and treatmentsManagement of metastatic bone disease